Only 0.04% of people face a 10% or higher risk of serious statin-related muscle disorders over a decade. That's the headline from a massive new study published Thursday in The Lancet Digital Health, which analyzed medical records from nearly 6 million adults in the United Kingdom. For context, previous American Heart Association estimates pegged the rate of statin-related myopathy at under 1% and rhabdomyolysis — the dangerous breakdown of muscle tissue —...